Related Experiment Video

Updated: Aug 10, 2026

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
05:57

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

Published on: July 2, 2013

Temperature-dependent resistance to gentamicin in graft keratitis by Stenotrophomonas (Xanthamonas) maltophilia

P R Richardson, M J Tappin, K J Thickett

    Eye (London, England)
    |January 1, 1997
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
    09:22

    Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis

    Published on: May 12, 2020

    Evaluating Therapeutic and Chemical Toxicity Using Organ-Cultured Porcine Corneas and Epithelial Wound Healing
    03:57

    Evaluating Therapeutic and Chemical Toxicity Using Organ-Cultured Porcine Corneas and Epithelial Wound Healing

    Published on: January 10, 2025

    Related Experiment Videos

    Last Updated: Aug 10, 2026

    The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
    05:57

    The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms

    Published on: July 2, 2013

    Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
    09:22

    Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis

    Published on: May 12, 2020

    Evaluating Therapeutic and Chemical Toxicity Using Organ-Cultured Porcine Corneas and Epithelial Wound Healing
    03:57

    Evaluating Therapeutic and Chemical Toxicity Using Organ-Cultured Porcine Corneas and Epithelial Wound Healing

    Published on: January 10, 2025

    Related Concept Videos

    Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

    Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

    Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

    Articles linked to this work by shared authors, journal, and citation graph.

    SMaSH: a scalable, general marker gene identification framework for single-cell RNA-sequencing.

    BMC bioinformatics·2022

    Search for Lepton-Flavor Violation in Z-Boson Decays with τ Leptons with the ATLAS Detector.

    Physical review letters·2022

    Search for New Phenomena in Final States with Two Leptons and One or No b-Tagged Jets at sqrt[s]=13 TeV Using the ATLAS Detector.

    Physical review letters·2021

    Search for Displaced Leptons in sqrt[s]=13 TeV pp Collisions with the ATLAS Detector.

    Physical review letters·2021

    Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into W^{±}W^{∓} or ZZ in Fully Hadronic Final States from sqrt[s]=13 TeV pp Collisions Recorded with the ATLAS Detector.

    Physical review letters·2021

    Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44 TeV with the ATLAS Detector.

    Physical review letters·2021

    Personalised ILM peeling for Myopic traction maculopathy.

    Eye (London, England)·2026

    Prelaminar hyperreflective lines in non-arteritic anterior ischaemic optic neuropathy.

    Eye (London, England)·2026

    Post-treatment residual masses in orbital lymphoma: incidence, risk factors, and prognostic impact.

    Eye (London, England)·2026

    Deep learning-based prediction of one-year functional and structural outcomes in treatment-naïve DMO after anti-VEGF therapy.

    Eye (London, England)·2026

    Persistent foetal vasculature: Developmental mechanisms, contemporary management and evolving therapeutics.

    Eye (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us